Latest filing published 04 Dec 2025 for Jazz Pharmaceuticals plc, €90k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.7%Entry US$111.54 · Close at T+365 US$133.53
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kenneth W. O'Keefe: trading record in brief
Kenneth W. O'Keefe, listed as senior executive, appears in our data through filings on Jazz Pharmaceuticals plc shares, published by SEC (Form 4). In total, 59 filings cover trades dated from 6 June 2007 to 2 December 2025.
In open-market terms, that means 4 purchases worth €209k on one side and 19 sales worth €67.0M on the other. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 25 share grants and 8 option exercises.
A typical purchase (the median) is worth €52k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +19.9%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 4 December 2025: a share grant of €90k, in Jazz Pharmaceuticals plc. The last purchase on record was published on 15 November 2016, which is 3,645 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kenneth W. O'Keefe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 603 shares@ US$173.0715.0% of flowOrdinary SharesSEC:0001397661-25-000009:0
- 1,805 shares@ US$111.253.8% of flowOrdinary SharesSEC:0001765581-25-000096:1
- 3,507 shares0Ordinary SharesSEC:0001765581-25-000096:0
- 1,484 shares@ US$111.353.3% of flowOrdinary SharesSEC:0001765581-24-000075:1
- 3,731 shares0Ordinary SharesSEC:0001765581-24-000075:0
- 1,241 shares@ US$138.163.5% of flowOrdinary SharesSEC:0001765581-23-000096:1
- 3,075 shares0Ordinary SharesSEC:0001765581-23-000096:0
- 2,690 shares@ US$138.397.7% of flowOrdinary SharesSEC:0001765581-23-000034:1
- 4,500 shares@ US$81.7657.6% of flowOrdinary SharesSEC:0001765581-23-000034:0
- 1,089 shares@ US$152.333.6% of flowOrdinary SharesSEC:0001765581-22-000092:1
- 2,561 shares0Ordinary SharesSEC:0001765581-22-000092:0
- 1,306 shares@ US$147.9627.3% of flowOrdinary SharesSEC:0001765581-21-000106:0
- 2,246 shares0Ordinary SharesSEC:0001765581-21-000077:0
- 2,740 shares@ US$153.742816.7% of flowOrdinary SharesSEC:0001765581-20-000111:1
- 1,746 shares@ US$155.135910.7% of flowOrdinary SharesSEC:0001765581-20-000111:2
- 4,513 shares@ US$156.437728.0% of flowOrdinary SharesSEC:0001765581-20-000111:3
- 2,001 shares@ US$152.571112.1% of flowOrdinary SharesSEC:0001765581-20-000111:0
- 22,249 sharesOrdinary SharesSEC:0001765581-20-000105:0
- 931 shares@ US$125.874.6% of flowOrdinary SharesSEC:0001765581-20-000077:1
- 2,705 shares0Ordinary SharesSEC:0001765581-20-000077:0
- 6,750 shares@ US$147.8227.8% of flowOrdinary SharesSEC:0001765581-19-000098:0
- 1,920 shares0Ordinary SharesSEC:0001765581-19-000070:0
- 726 shares@ US$135.652.7% of flowOrdinary SharesSEC:0001765581-19-000070:1
- 1,495 shares0Ordinary SharesSEC:0001232524-18-000148:0
- 660 shares@ US$176.613.1% of flowOrdinary SharesSEC:0001232524-18-000148:1
25 of 49 declarations
